Aphex BioCleanse Systems (Aphex BioCleanse Systems) Debt-to-Revenue : 0.00 (As of . 20)

View and export this data going back to . Start your Free Trial

What is Aphex BioCleanse Systems Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Aphex BioCleanse Systems's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was $0.00 Mil. Aphex BioCleanse Systems's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was $0.00 Mil. Aphex BioCleanse Systems's annualized Revenue for the quarter that ended in . 20 was $0.00 Mil.

Aphex BioCleanse Systems Debt-to-Revenue Historical Data

The historical data trend for Aphex BioCleanse Systems's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aphex BioCleanse Systems Debt-to-Revenue Chart

Aphex BioCleanse Systems Annual Data

Trend

Debt-to-Revenue

Aphex BioCleanse Systems Quarterly Data

Debt-to-Revenue

Competitive Comparison of Aphex BioCleanse Systems's Debt-to-Revenue

For the Household & Personal Products subindustry, Aphex BioCleanse Systems's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aphex BioCleanse Systems's Debt-to-Revenue Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Aphex BioCleanse Systems's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Aphex BioCleanse Systems's Debt-to-Revenue falls into.

Aphex BioCleanse Systems Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Aphex BioCleanse Systems's Debt-to-Revenue for the fiscal year that ended in . 20 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(	+	)	/	N/A
	=	N/A

Aphex BioCleanse Systems's annualized Debt-to-Revenue for the quarter that ended in . 20 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(	+	)	/	0
	=	N/A

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (. 20) Revenue data.

Aphex BioCleanse Systems Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Aphex BioCleanse Systems's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Aphex BioCleanse Systems (Aphex BioCleanse Systems) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Aphex BioCleanse Systems Inc (OTCPK:SNST) » Definitions » Debt-to-Revenue

Traded in Other Exchanges

N/A

Address

1820 State Road 13, Unit 11-43, Saint Johns, FL, USA, 32259

Website

https://www.aphexus.com

Aphex BioCleanse Systems Inc is a United States-based company that provides sanitization solutions. It develops and manufactures non-alcohol, non-toxic, and hydrogen-based disinfecting technology. The company produces proprietary hydrogen-based disinfectant and pesticide products known as Hy-IQ Water.